Early screening for prostate cancer is such an important part of men’s health because it has become the second most common cancer in men in the United States. For those men who have had a family history of prostate cancer, they have a much higher risk of developing it themselves. The Prostate-specific antigen screening has been shrouded in controversy as an effective way to screen for the disease. This screening has shown to have plenty of benefits that do no harm but are also shown to have negative effects that cause more harm than good. This episode will look into the tough decision organizations have to make on whether or not to recommend this screening to patients.